Board to approve September 2026 quarterly and half-year results

Results View source PDF Explain this filing

ARTEMISMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.0%Reaction day

₹288.00

prior close

₹301.25

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.7%+2.3% vs market

Hospital peers, median of 27sector+1.4%+2.6% vs sector

On the reaction day the stock moved 2.3 pts more than Nifty Microcap 250 and 2.6 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

-0.1

15m

-0.6

30m

-0.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.0+1.7+2.3+1.4+2.6

Next day

+3.8pendingpending+2.2+1.6

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The Board will meet on October 30, 2026 to approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. Trading in the company’s securities remains closed from October 1 through November 1, 2026, or 48 hours after results are declared.

Likely market impact

Only the results date and trading-window closure are announced. No financial figures are provided, so the stock's direction cannot yet be assessed.